REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 25 filers reported holding REDHILL BIOPHARMA LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $32,000 | +23.1% | 3,000 | 0.0% | 0.01% | +18.2% |
| Q2 2017 | $26,000 | -10.3% | 3,000 | 0.0% | 0.01% | -15.4% |
| Q1 2017 | $29,000 | -6.5% | 3,000 | 0.0% | 0.01% | -7.1% |
| Q4 2016 | $31,000 | -26.2% | 3,000 | 0.0% | 0.01% | -26.3% |
| Q3 2016 | $42,000 | +27.3% | 3,000 | 0.0% | 0.02% | +26.7% |
| Q2 2016 | $33,000 | -10.8% | 3,000 | 0.0% | 0.02% | -16.7% |
| Q1 2016 | $37,000 | -26.0% | 3,000 | -22.9% | 0.02% | -25.0% |
| Q4 2015 | $50,000 | 0.0% | 3,890 | 0.0% | 0.02% | -4.0% |
| Q3 2015 | $50,000 | -27.5% | 3,890 | 0.0% | 0.02% | -19.4% |
| Q2 2015 | $69,000 | +21.1% | 3,890 | 0.0% | 0.03% | +24.0% |
| Q1 2015 | $57,000 | +9.6% | 3,890 | 0.0% | 0.02% | +8.7% |
| Q4 2014 | $52,000 | -10.3% | 3,890 | -11.6% | 0.02% | -14.8% |
| Q3 2014 | $58,000 | -24.7% | 4,400 | 0.0% | 0.03% | -25.0% |
| Q2 2014 | $77,000 | – | 4,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,714,880 | $2,428,000 | 0.55% |
| Broadfin Capital, LLC | 263,160 | $3,708,000 | 0.36% |
| Orbimed Advisors | 631,580 | $8,899,000 | 0.11% |
| Tower Research Capital LLC (TRC) | 795 | $11,000 | 0.00% |
| MORGAN STANLEY | 2 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,000 | $42,000 | 0.00% |
| CITIGROUP INC | 100 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 29,000 | $409,000 | 0.00% |
| UBS AG | 300 | $4,000 | 0.00% |